| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 43.38% | -19.01% | -13.41% | 87/140 | 52.37% | 健帆生物 | 78.46% | 行业排名> |
| 2025-12-31 | 50.1% | -3.86% | 1.19% | 74/140 | 51.9% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-09-30 | 49.51% | -8.59% | -4.82% | 76/140 | 52.23% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-06-30 | 52.02% | -6.65% | -2.89% | 72/140 | 52.43% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-03-31 | 53.56% | 0.47% | 2.79% | 66/140 | 52.13% | 佰仁医疗 | 88.54% | 行业排名> |
| 2024-12-31 | 52.11% | -9.21% | -3.78% | 73/140 | 53.08% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-09-30 | 54.16% | -3.98% | -2.8% | 67/140 | 53.87% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-06-30 | 55.72% | -0.79% | 4.51% | 66/140 | 53.95% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-03-31 | 53.31% | -5.6% | -7.12% | 67/140 | 53.88% | 佰仁医疗 | 89.27% | 行业排名> |
| 2023-12-31 | 57.4% | 34.92% | 1.76% | 61/140 | 53.57% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-09-30 | 56.41% | 29.21% | 0.43% | 65/140 | 54.44% | 正海生物 | 89.9% | 行业排名> |
| 2023-06-30 | 56.16% | 35.67% | -0.55% | 65/140 | 53.81% | 正海生物 | 90.39% | 行业排名> |
| 2023-03-31 | 56.47% | 49% | 32.74% | 63/140 | 54.06% | 正海生物 | 90.3% | 行业排名> |
| 2022-12-31 | 42.55% | -18.91% | -2.54% | 94/140 | 54.01% | 万泰生物 | 91.61% | 行业排名> |
| 2022-09-30 | 43.65% | -17.44% | 5.45% | 83/140 | 55.7% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 41.4% | -24.38% | 9.22% | 95/140 | 55.37% | 三友医疗 | 90.14% | 行业排名> |
| 2022-03-31 | 37.9% | -29.87% | -27.76% | 91/140 | 56.89% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 52.47% | -3.39% | -0.77% | 82/140 | 57.98% | 三友医疗 | 90.73% | 行业排名> |
| 2021-09-30 | 52.87% | -3.58% | -3.41% | 71/140 | 59.77% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 54.74% | 3.21% | 1.29% | 75/140 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2021-03-31 | 54.05% | 15.98% | -0.48% | 67/140 | 61.5% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 54.31% | -0.7% | -0.96% | 82/140 | 60.12% | 正海生物 | 91.59% | 行业排名> |
| 2020-09-30 | 54.84% | -0.13% | 3.39% | 60/140 | 62.21% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 53.04% | -2.73% | 13.82% | 75/140 | 60.36% | 正海生物 | 92.69% | 行业排名> |
| 2020-03-31 | 46.6% | -4.84% | -14.79% | 53/140 | 58.8% | 正海生物 | 92.61% | 行业排名> |
| 2019-12-31 | 54.69% | 10.96% | -0.39% | 64/140 | 56.96% | 正海生物 | 94.38% | 行业排名> |
| 2019-09-30 | 54.91% | 12.14% | 0.7% | 33/140 | 55.83% | 正海生物 | 93.12% | 行业排名> |
| 2019-06-30 | 54.53% | 12.38% | 11.35% | 41/140 | 57.93% | 正海生物 | 93.78% | 行业排名> |
| 2019-03-31 | 48.97% | 9.54% | -0.65% | 27/140 | 52.61% | 正海生物 | 93.09% | 行业排名> |
| 2018-12-31 | 49.29% | -10.62% | 0.67% | 66/140 | 56.22% | 正海生物 | 93.85% | 行业排名> |
| 2018-09-30 | 48.97% | -10.27% | 0.92% | 28/140 | 52.76% | 正海生物 | 93.08% | 行业排名> |
| 2018-06-30 | 48.52% | -10.96% | 8.53% | 32/140 | 53.06% | 正海生物 | 92.83% | 行业排名> |
| 2018-03-31 | 44.71% | -18.23% | -18.93% | 29/140 | 52.55% | 正海生物 | 92.44% | 行业排名> |
| 2017-12-31 | 55.15% | -0.05% | 1.06% | 56/140 | 56.1% | 正海生物 | 92.7% | 行业排名> |
| 2017-09-30 | 54.57% | -2.11% | 0.14% | 22/140 | 53.53% | 正海生物 | 93.67% | 行业排名> |
| 2017-06-30 | 54.49% | -2.39% | -0.33% | 30/140 | 54.85% | 正海生物 | 94.14% | 行业排名> |
| 2017-03-31 | 54.68% | -3.98% | -0.91% | 22/140 | 54.29% | 正海生物 | 93.83% | 行业排名> |
| 2016-12-31 | 55.18% | -4.49% | -1.02% | 42/140 | 57.35% | 正海生物 | 93.69% | 行业排名> |
| 2016-09-30 | 55.74% | -3.18% | -0.15% | 16/140 | 51.85% | 正海生物 | 92.79% | 行业排名> |
| 2016-06-30 | 55.83% | 3.56% | -1.96% | 22/140 | 52.6% | 健帆生物 | 84.23% | 行业排名> |
| 2016-03-31 | 56.94% | 14.23% | -1.43% | 13/140 | 50.24% | *ST明德 | 86.71% | 行业排名> |

微信公众号
证券之星APP


